FDA has proposed mandatory notification for covered GRAS uses in human and animal food, including certain food-contact substances. Learn what could change, which uses in your portfolio may be affected and what your regulatory team can do now.
FDA’s rule is proposed, not final. Public comments are due Dec. 9, 2026.
Talk to a GRAS ExpertWhat FDA’s GRAS Proposal Would Change
FDA’s August 2026 proposal would replace voluntary GRAS notification with mandatory notification for covered uses. Companies could still reach their own GRAS conclusions, but notification to FDA would no longer be optional for covered uses unless an exception applies.

If finalized, the proposal would:
- Require notification for covered human and animal food uses that do not qualify for an exception, including certain food-contact substances
- Create a time-limited, streamlined pathway for certain substances already marketed under independent GRAS conclusions
- Increase FDA and public visibility by making filed GRAS notices and related information publicly available
The proposal would also make failure to meet an applicable notification requirement a factor FDA considers when prioritizing substances for post-market review.
Mandatory notification would not turn GRAS into a premarket approval program. Under the proposal, a company could continue marketing a substance while FDA evaluates its notice.
Where Should Your Regulatory Team Focus Now?
You don’t need to wait for a final rule to understand how your portfolio could be affected.
Focus on three areas:
- Inventory your GRAS uses
Identify substances and intended uses relying on independent GRAS conclusions, as well as uses already covered by FDA “no questions” letters or other potential exceptions. Include relevant food-contact substances. - Review the basis for each determination
Confirm that your documentation reflects current manufacturing methods, intended uses, use levels and supporting safety information. - Prioritize gaps
Identify ingredients, suppliers or uses that may need additional documentation, notification planning or regulatory review if the rule becomes final.
FoodChain ID helps you prepare for GRAS

Get expert help with your GRAS strategy
FoodChain ID’s regulatory and scientific experts can help you understand which GRAS uses may be affected and prepare for the path ahead

Review documentation and prepare GRAS notices
Evaluate existing GRAS files for gaps and develop the identity, manufacturing, specifications, exposure and safety information needed for an FDA-ready GRAS notice

Assess your portfolio and regulatory pathway
Rank items by regulatory and commercial impact so your team focuses on the highest-risk products first

Manage submission and FDA follow-up
Prepare and submit GRAS notices and support filing determinations, clarification requests, deficiencies and other FDA questions throughout the review process
Understand What the Proposed GRAS Rule Could Mean for Your Portfolio
Tell us what GRAS questions your organization is working through. A FoodChain ID expert will follow up to discuss your ingredient portfolio and regulatory priorities.